COLIBRA

[ Diagnostic and therapeutic synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitounrinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; diagnostic preparations for medical use, namely, synthetic peptides, proteins, molecules, antibodies, polypeptides and polymers for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, opthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biochemical and biological substances for medical diagnosis and analytics, namely, pharmaceutical preparations and substances for the diagnosis and analytics of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders ]

Scientific, biological, biochemical, and biotechnology research in the field of in-vitro screening and protein engineering; biochemical research services; biotechnological engineering, namely, the engineering of peptides, proteins, molecules, antibodies, polypeptides and polymers

Licensing of intellectual property; licensing of technology in the field of in-vitro screening and protein engineering relating to discovery of peptides for therapeutic and non-therapeutic applications